Collaborative Practice Agreement In Nurse Prescribing

No agreement on common practice can effectively cover any clinical situation. Therefore, the collaborative practice agreement is not intended to replace the exercise of a professional assessment with the nurse and should not be. There are situations where patient care is both frequent and unusual and requires the individual exercise of the nurse-practitioner`s clinical judgment. This is not an exhaustive list of questions or statements to consider for your collaborative practice agreement, but is intended to guide your development of the collaborative practice agreement for your practice. What medications, devices, medical treatments, tests and procedures that can be prescribed, ordered and performed would be appropriate for the diagnosis and treatment of common medical problems in your nurse practitioner practice? The NMBI Board of Directors approved the repeal of the Collaborative Practice Agreement (CPA) on April 17, 2018, a precondition for the registration and regulation of nurses and midwives. The clinical governance of prescription drugs is now determined by the local health care provider`s policy, procedures, protocols or guidelines (PPPG). How will patient advice and transfers be made in your practice? The n.K.-registered nurse or midwife is required to prescribe within her field of activity and must continue to maintain and prove her competence in fulfilling her role. The registered midwife nurse or prescriber must also conduct a review of her prescribing practices, which is established by her local health care provider`s audit procedure for drug and prescription management. The result of the review of prescribing practices must be documented and reported to the person who has the overall responsibility and authority of the registered nurse or midwife`s management who prescribes in her health care provider.

Rules 21NCAC36.0810 (b) (1) (2) and 21 NCAC32M.0110(b) (1) (2) “Quality Assurance Standards for a Collaborative Practice Agreement” conclude and maintain the agreement on collaborative practice by both the primary physician and the specialist and maintained at each place of practice. What will be your process, developed by the nurse and primary supervisor for the ongoing review of care at each training site, including a written plan to assess the quality of care provided for one or more common clinical problems? The Director of Nursing/Midwives/Public Health Services or his or her designated person must have the overall responsibility and authority of the registered nurse and midwife who prescribe to ensure the imperatives of care in their health care provider (NMBI and NMSD, HSE 2015). What medications and devices will you prescribe in each place of exercise? You can list certain drugs or certain categories of drugs. A complete description of the categories of drugs and devices to treat common health problems in your particular practice can be developed. For example: categories of drugs, such as anti-Semitic drugs, hypoglycemics-oral/insulin, oral hormones and contraceptives, cephalosporins, aminoglycosides, antivirals, antiasthmatics, diuretics, antihypertensivus, etc. may be indicated. Exceptions may be granted by classes of drugs or certain drugs in a class or administration routes.